Publication dates

All regions

Melanoma Industry, August 2014 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, breast cancer, more »


 
1-20 of about 8 600 reports for Melanoma

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

  • $ 3 900
  • Industry report
  • August 2014
  • by Firstword Pharma

... In the areas of breast cancer, melanoma, nsclc, and renal cell carcinomaunderstand the key issues for which physicians require medical affairs team support ...

Trends in Therapeutic Partnering

Trends in Therapeutic Partnering

  • $ 3 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Malaria partnering in numberstop malaria partnering deals by valuemost active malaria partnering companies33. melanomamelanoma partnering in numberstop melanoma partnering deals by value ...

Melanoma Partnering 2009-2014

Melanoma Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

... To the contract. Chapter 4 provides a comprehensive directory of melanoma partnering deals signed and announced since 2009. The chapter is organized by company a-z, stage of development at signing, deal ...

Cancer Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cancer Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Immunology and cancer immunology research. It conducts clinical trials for several cancer types such as breast cancer, colorectal cancer, lung cancer, melanoma and prostate cancer. The institute ...

PDS Biotechnology Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PDS Biotechnology Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Of hpv-related cancers, and pds0102 for the treatment of melanoma. It also offers vaccines to prevent and to treat infectious diseases. The company partners with merck eprova ag, nanotechnology ...

Melanoma Drug Pipeline Update 2014

Melanoma Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Suspended drugs and the accumulated number of ceased drugs over the last years amount to another 134 drugs. melanoma drug pipeline update lists all drugs and gives you a progress analysis on each one of them ...

Melanoma Drug Pathway Analyzer 2014

Melanoma Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the melanoma ...

Genomic Health, Inc. (GHDX) - Product Pipeline Analysis, 2014 Update

Genomic Health, Inc. (GHDX) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • July 2014
  • by Global Data

... And colon cancers. Further, the company is performing additional research activities in the areas of renal cancer; non-small cell lung cancer; and melanoma. Genomic health develops these products using ...

Oxford Biodynamics Limited - Product Pipeline Analysis, 2014 Update

Oxford Biodynamics Limited - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • July 2014
  • by Global Data

... Product status 22episwitch obd27 breast cancer test - product description 22episwitch obd29 melanoma diagnostic test - product status 23episwitch obd29 melanoma diagnostic test - product ...

 Metastatic Melanoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Metastatic Melanoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... And exclusivity details of metastatic melanoma key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under ...

About 1 700 reports for Melanoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe - Forecast

  • May 2014
    5 pages
  • Melanoma  

    Drug  

  • Europe  

    Italy  

    Germany  

View report >

2 Companies for Melanoma

Read our Company Profiles

Novartis Inc.

Switzerland

Eli Lilly and Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.